Author: Fiona Craig

  • Private Credit Concerns Build; U.S. PCE and GDP Reports in Focus – Market Drivers: Dow Jones, S&P, Nasdaq, Wall Street Futures

    Private Credit Concerns Build; U.S. PCE and GDP Reports in Focus – Market Drivers: Dow Jones, S&P, Nasdaq, Wall Street Futures

    U.S. equity futures traded higher early Friday as investors prepared for pivotal readings on inflation and economic growth. At the same time, anxiety intensified around the private credit space following an announcement from Blue Owl Capital (NYSE:OWL), while crude prices steadied amid ongoing geopolitical strains between Washington and Tehran.

    Futures Move Higher

    As of 03:09 ET, Dow Jones futures were up 54 points, or 0.1%. S&P 500 futures gained 14 points, or 0.2%, and Nasdaq 100 futures climbed 57 points, also 0.2%.

    Wall Street’s major benchmarks had closed lower in the previous session, pressured by concerns over Middle East tensions and a series of earnings releases that analysts at Vital Knowledge labeled as “underwhelming.” Retail heavyweight Walmart (NYSE:WMT) warned that inflation in general merchandise had accelerated sharply due to sweeping U.S. tariffs and issued cautious guidance for the current year, pushing its stock lower.

    Shares of Apple (NASDAQ:AAPL) also declined, weighing on the broader S&P 500.

    On the monetary policy front, Federal Reserve Governor Stephen Miran appeared to soften his previously dovish stance on interest rates. His remarks followed the release of minutes from the Fed’s January meeting, which indicated that several policymakers had cautioned about the possibility of rate hikes in the months ahead. According to Vital Knowledge, this reinforces the view that borrowing costs may be “heading further away” from President Donald Trump’s preference for swift and aggressive rate cuts. The analysts added that such divergence increases the likelihood of friction between the White House and the Federal Reserve.

    Private Credit Under Pressure

    Market attention on Thursday centered on the private credit industry after Blue Owl Capital announced changes to its redemption framework. Investors will no longer be able to withdraw a fixed amount of capital each quarter.

    Instead, the firm will determine on a quarterly basis how much capital it returns to investors.

    Blue Owl’s shares fell in response, as did those of peers including Ares (NASDAQ:ARCC) and Blackstone (NYSE:BX). The reaction highlighted rising unease about potential weaknesses in the largely opaque private credit market, which has extended trillions of dollars in loans to companies over recent years.

    Concerns are also mounting over lenders’ exposure to software companies, a segment that has faced pressure as investors assess potential disruptions stemming from the rapid development of new artificial intelligence models.

    In a post on social media, former PIMCO CEO Mohamed El-Erian questioned whether Blue Owl’s revised redemption terms represent a “canary-in-the-coalmine” moment, drawing parallels with early warning signs seen before the global financial crisis nearly two decades ago.

    “There’s plenty to think about here, starting with the risks of an investing phenomenon in advanced (not developing) markets that has gone too far overall (short answer: yes), to the approaches being taken by specific firms (lots of differences, yet subject to the “market for lemons” risk),” El-Erian wrote.

    Oil Holds Firm

    Oil prices stabilized and remained on course for their first weekly gain in three weeks, as escalating U.S.–Iran tensions heightened concerns about potential supply disruptions in the Middle East.

    Brent crude futures were trading broadly unchanged at $71.66 per barrel, while U.S. West Texas Intermediate crude futures slipped 0.1% to $66.35 per barrel.

    Both benchmarks hovered near their highest levels since early August and were set to post weekly gains of more than 6%.

    Geopolitical risks intensified after Trump warned on Thursday that “really bad things” would happen if Iran failed to reach a nuclear agreement within 10 to 15 days, raising the possibility of military action.

    Any escalation involving Iran — a major OPEC producer — could disrupt flows through the Strait of Hormuz, a critical transit route for roughly one-fifth of global oil shipments.

    PCE Data Ahead

    Investors are closely watching Friday’s economic releases, with particular focus on the personal consumption expenditures (PCE) price index.

    The core PCE gauge, closely monitored by the Federal Reserve, is expected to rise 0.3% month over month in December, compared with 0.2% in November. On a year-over-year basis, it is forecast at 3.0%, up from 2.8%, according to estimates from the Bureau of Economic Analysis.

    Data released last week showed that headline consumer price inflation rose more slowly than anticipated in January, strengthening expectations that the Fed could bring forward the timing of its next rate cut to as early as June. However, a stronger-than-expected labor market report earlier this week had tempered those bets, suggesting the central bank — which reduced rates multiple times in 2025 — may hold off on further easing until the second half of the year.

    U.S. GDP Estimate Due

    Meanwhile, an advance estimate of fourth-quarter U.S. economic growth is expected to show a moderation in momentum during the October–December period.

    Economists forecast that the U.S. economy expanded at an annualized rate of 2.8% in the final three months of 2025, slowing from 4.4% in the third quarter.

    In the prior quarter, consumer spending — long the backbone of U.S. economic activity — continued to play a central role in driving growth. A narrowing trade deficit, partly linked to President Trump’s broad tariff measures, also contributed to the expansion.

    Although the headline figures appear solid, many Wall Street observers argue that the economy has developed a “K” shape. Higher-income households and large corporations have shouldered much of the growth, while lower-income Americans continue to grapple with elevated prices and a subdued hiring environment. Smaller businesses, meanwhile, face rising import costs and tighter labor supply conditions due to ongoing immigration restrictions.

  • European Equities Edge Higher as Earnings Roll In; UK Retail Sales Surprise to the Upside:

    European Equities Edge Higher as Earnings Roll In; UK Retail Sales Surprise to the Upside:

    European markets traded modestly higher on Friday as investors assessed a fresh batch of corporate results and economic indicators, while keeping a close watch on geopolitical tensions between Washington and Tehran.

    At 08:05 GMT, Germany’s DAX advanced 0.2%, France’s CAC 40 gained 0.5% and London’s FTSE 100 rose 0.4%.

    Earnings Season Wraps Up

    The busy quarterly reporting calendar is drawing to a close, but several notable updates continued to shape sentiment.

    Anglo American plc (LSE:AAL) reported a $3.7 billion loss after booking another sizeable impairment related to its diamond operations. The miner is continuing efforts to dispose of non-core assets while progressing its planned merger with Teck Resources.

    Danone (EU:BN) said it is entering 2026 with confidence after delivering 2025 sales and cash generation above expectations. Demand for infant nutrition in China supported growth, while cost-control measures helped lift margins.

    Swiss chemicals group Sika AG (TG:SIKA) posted a 16% drop in annual net profit, reflecting weaker construction demand in China and a downturn in U.S. commercial building activity following an extended government shutdown.

    Aston Martin Lagonda Global Holdings plc (LSE:AML) reported lower full-year wholesale volumes and confirmed it will sell the naming rights of its Formula One team to an affiliate for £50 million in cash.

    Pharmaceutical major AstraZeneca (LSE:AZN) announced that the U.S. Food and Drug Administration has approved Calquence as the first fully oral, fixed-duration therapy for adult patients with chronic lymphocytic leukaemia and small lymphocytic lymphoma.

    UK Retail Sales Jump

    On the macro front, UK retail activity surprised on the upside in January, pointing to resilient consumer demand at the start of the year.

    Retail sales increased 1.8% month on month, accelerating from December’s 0.4% rise, according to the Office for National Statistics. On an annual basis, sales grew 4.5%, compared with a revised 1.9% increase in the prior month, previously reported as 2.5%.

    Elsewhere, German producer prices declined 3% year on year in January, a steeper drop than the 2.1% fall expected by economists.

    Investors are also awaiting eurozone PMI readings later in the session. In the United States, attention will turn to the core PCE price index — the Federal Reserve’s preferred inflation gauge — due for release later in the day.

    Recent U.S. data showed headline consumer price inflation rose more slowly than expected in January, reinforcing expectations that the Fed could begin cutting interest rates as early as June.

    Oil Set for Weekly Gain

    Crude prices steadied on Friday and remained on track for their first weekly advance in three weeks, amid renewed concerns over Middle East supply risks.

    Brent crude traded broadly unchanged at $71.66 per barrel, while U.S. West Texas Intermediate slipped 0.1% to $66.35. Both benchmarks hovered near their highest levels since early August and were poised to gain more than 6% for the week.

    Tensions escalated after U.S. President Donald Trump warned on Thursday that “really bad things” would happen if Iran fails to reach an agreement on its nuclear program within 10 to 15 days, raising the possibility of military action.

    Any escalation involving Iran — a key OPEC producer — could disrupt shipments through the Strait of Hormuz, a vital passageway for roughly 20% of global oil flows.

  • Diageo Chief Executive Said to Be Preparing Broad Management Overhaul

    Diageo Chief Executive Said to Be Preparing Broad Management Overhaul

    Diageo plc (LSE:DGE) Chief Executive Sir Dave Lewis is reportedly lining up a far-reaching reshuffle of the group’s senior leadership as part of efforts to tackle internal cultural challenges, according to sources cited by the Financial Times.

    The report, referencing individuals familiar with the matter, says Lewis intends to replace several members of Diageo’s 14-strong executive committee. The move would form part of a broader transformation plan at the London-based drinks giant, which owns global brands including Johnnie Walker whisky, Captain Morgan rum and Guinness.

    One source described the proposed reforms as sweeping in scope, suggesting the new CEO is considering substantial structural changes. The same individual indicated that decision-making within the company had become overly complex and that a degree of complacency had set in across parts of the organisation, which employs more than 29,000 people worldwide.

    Although no formal announcements are expected at next week’s interim results, investors are said to be anticipating decisive steps as part of a wider turnaround strategy. Another person familiar with Lewis’s approach suggested that the overhaul could involve eliminating entire layers of management in an effort to streamline operations and improve accountability.

  • FTSE 100 Rises While Sterling Slips Below $1.35; Anglo American and Aston Martin in Spotlight

    FTSE 100 Rises While Sterling Slips Below $1.35; Anglo American and Aston Martin in Spotlight

    London equities moved higher on Friday, with the FTSE 100 advancing as broader European markets also traded in positive territory. Meanwhile, sterling edged lower against the dollar, slipping beneath the $1.35 mark, as investors digested corporate developments from Anglo American and Aston Martin.

    By 08:45 GMT, the benchmark FTSE 100 was up 0.3%, while the pound declined 0.1% to $1.3451. On the continent, Germany’s DAX added 0.1% and France’s CAC 40 gained 0.6%.

    UK Market Round-Up

    Economic update – UK consumer spending showed strong momentum at the start of the year. Retail sales rose 1.8% month on month in January, well above December’s 0.4% increase and significantly exceeding economists’ expectations of a 0.2% gain. On an annual basis, sales climbed 4.5%, outperforming forecasts of 2.8%. Data from the Office for National Statistics pointed to a solid rebound in goods-related consumption.

    Aston Martin Lagonda Global Holdings plc (LSE:AML) – The luxury carmaker reported lower wholesale volumes for 2025, delivering 5,448 vehicles compared with 6,030 in the previous year. In a move to strengthen its liquidity position, the group agreed to sell its Formula One naming rights to a related entity for £50 million. Management expects gross margins for 2025 to come in at around 29.5%.

    Anglo American plc (LSE:AAL) – The miner posted a $3.7 billion loss, primarily due to additional impairments in its diamond division. The company continues to streamline its portfolio by divesting non-core assets while advancing plans for a merger with Teck Resources.

    Tullow Oil plc (LSE:TLW) – The oil producer generated approximately $100 million in free cash flow in 2025, below earlier guidance. Average daily output stood at 40.4 thousand barrels of oil equivalent per day, reflecting the impact of the sale of its Gabon operations. The group recently completed a refinancing agreement to restructure its debt.

    AstraZeneca (LSE:AZN) – The U.S. Food and Drug Administration approved Calquence, in combination with venetoclax, as a fixed-duration, all-oral therapy for certain forms of leukemia and lymphoma. The decision follows positive Phase III trial results published in the New England Journal of Medicine.

    HSBC Holdings plc (LSE:HSBA) – As part of a broader cost-cutting initiative, the banking group has reportedly reduced its U.S. debt capital markets workforce by around 10%. The cuts included several senior roles in New York, spanning analysts through to managing director level.

    Diageo plc (LSE:DGE) – Chief executive Dave Lewis is said to be preparing changes to the company’s 14-member executive committee. The reported overhaul is aimed at tackling internal cultural issues within the drinks group, which owns brands such as Johnnie Walker and Guinness.

  • Tullow Oil plc Agrees Landmark Refinancing With Noteholders and Glencore

    Tullow Oil plc Agrees Landmark Refinancing With Noteholders and Glencore

    Tullow Oil (LSE:TLW) has reached agreement on a wide-ranging refinancing with approximately two-thirds of its senior secured noteholders and Glencore, reshaping its debt profile and extending maturities. The transaction replaces the company’s 2026 senior secured notes with new “Extended Notes” due in November 2028, alongside new junior notes issued to Glencore maturing in 2030.

    The restructuring reduces near-term refinancing pressure, lowers overall cash interest costs and avoids equity dilution. It also introduces enhanced creditor oversight, including the appointment of at least three new independent non-executive directors and the creation of a dedicated value maximisation committee at board level.

    As part of the package, $1.285 billion of existing senior secured notes and Glencore’s $400 million facility will be written down and exchanged. The agreement also includes a mandatory repayment of at least $100 million on the new notes and establishes a new $100 million super senior cargo prepayment facility secured against Ghanaian oil cargoes.

    By extending its debt maturities and stabilising its capital structure, Tullow aims to create financial flexibility to deliver its 2026–2027 investment plans in Ghana. Priorities include securing licence extensions, addressing outstanding tax and receivable matters with the government, and advancing drilling programmes, gas monetisation projects and potential FPSO ownership initiatives. Management believes these steps could support long-term production stability and value creation for both creditors and shareholders.

    From an investment perspective, the company continues to face material balance sheet risks, including negative equity and elevated leverage, despite solid operating cash generation. Technical indicators show improving short-term momentum, though the broader long-term trend remains fragile. Valuation metrics offer limited comfort, with a negative price-to-earnings ratio and no dividend yield currently in place.

    More about Tullow Oil

    Tullow Oil plc is an independent upstream oil and gas company with its core producing assets in Ghana’s Jubilee and TEN fields. Listed in London and Ghana, the group focuses on exploration and production across West Africa, monetising crude oil and gas through established offtake and infrastructure arrangements while pursuing cost efficiencies and production optimisation to enhance reserves and cash flow generation.

  • Chemring Group plc Maintains FY26 Guidance as Record Order Book Underpins Growth

    Chemring Group plc Maintains FY26 Guidance as Record Order Book Underpins Growth

    Chemring (LSE:CHG) said trading for fiscal 2026 remains consistent with board expectations, despite a marginally slower start to the year. The group reported a record order book of £1.364 billion and noted that around 85% of expected revenues are already covered by first-quarter performance and contracted work. Demand continues to be supported by rising defence budgets among NATO members and allied nations, although first-quarter order intake was lower year on year following an unusually strong prior period that included several large, multi-year contract wins.

    Operationally, the company is centralising production at its automated Kilgore Flares facility in the United States. While this restructuring is expected to result in a non-cash impairment charge, management anticipates improved operational efficiency over time. Chemring is also progressing with substantial, debt-funded capital investment to expand capacity within its Energetics division, positioning the business to meet sustained demand for munitions and related products.

    The group acknowledged continued disruption in the UK defence market, driven by delays in strategic planning and procurement decisions. However, it pointed to improving order trends, new multi-year countermeasures agreements and ongoing progress at its Roke technology business. The company also confirmed a board change, with its senior independent director stepping down and an interim successor appointed.

    From a market perspective, Chemring’s fundamentals are supported by strong operational performance and positive commentary, particularly within Energetics. Nonetheless, technical indicators currently appear cautious, and a relatively elevated price-to-earnings ratio suggests valuation sensitivity. While the record order book and long-term defence spending trends underpin the growth case, cash flow pressures and valuation considerations temper the overall outlook.

    More about Chemring

    Chemring Group is a UK-based defence and security technology supplier serving military, security and space markets. The company operates through two primary divisions: Countermeasures & Energetics, and Sensors & Information. It provides advanced materials, munitions, countermeasure systems and specialist sensing technologies, with a core customer base spanning NATO countries and allied defence organisations.

  • SkinBioTherapeutics plc Appoints FRP Advisory for Independent Forensic Review

    SkinBioTherapeutics plc Appoints FRP Advisory for Independent Forensic Review

    SkinBioTherapeutics (LSE:SBTX), the AIM-listed skin health specialist based in Newcastle, has engaged FRP Advisory to carry out an independent forensic review into previously disclosed matters. The move is intended to bring clarity to outstanding issues and support the timely publication of interim results.

    The board has appointed new Non-Executive Director and Audit Committee Chair Alyson Levett to oversee the investigation process. Her role will include supervising the review on behalf of the board and ensuring appropriate governance standards are maintained throughout. Management said the objective is to conclude the process as swiftly as possible so that financial reporting can proceed with confidence and focus can return to operational priorities and growth initiatives.

    SkinBioTherapeutics continues to pursue expansion both organically and through acquisitions in complementary skincare and cosmetic segments, aiming to widen distribution channels, extend geographic reach and enhance manufacturing capabilities. The group seeks to apply its platform technologies across multiple skin health categories while leveraging consolidation opportunities to strengthen routes to market for its proprietary brands.

    From an investment standpoint, the company’s profile remains challenged by weak technical momentum and a pronounced downtrend in the share price, alongside ongoing losses and negative cash flow. These factors are partly balanced by strong revenue growth and what management describes as a relatively prudent balance sheet.

    More about SkinBioTherapeutics

    SkinBioTherapeutics is a UK life sciences company focused on dermatological health, built around its proprietary SkinBiotix technology originating from research at the University of Manchester. Its activities span cosmetic skincare and gut-skin axis supplements, marketed under brands including SkinBiotix and AxisBiotix, as well as Zenakine through a partnership with Croda. Products are distributed directly to consumers online, via Amazon and through selected Superdrug stores.

  • Anglo American plc Reports 2025 Loss While Advancing Teck Deal and Portfolio Overhaul

    Anglo American plc Reports 2025 Loss While Advancing Teck Deal and Portfolio Overhaul

    Anglo American (LSE:AAL) delivered a modest increase in underlying EBITDA from continuing operations to $6.4 billion in 2025, supported by solid production performance, disciplined cost management and strong margins in copper and premium iron ore. The group achieved $1.8 billion in annualised cost savings and reduced net debt to $8.6 billion, reflecting improved cash generation and tighter capital allocation.

    Despite these operational improvements, the company reported a $3.7 billion loss attributable to shareholders. The headline deficit was driven primarily by a $2.3 billion impairment at De Beers. At the same time, Anglo American is progressing with the disposal of its steelmaking coal, nickel and platinum businesses, while pursuing regulatory clearances for its proposed merger with Teck. The combination is expected to materially increase its copper exposure and reposition the group more firmly within the global critical minerals landscape.

    In addition to financial updates, the miner reported further advances in safety performance, lower greenhouse gas emissions and reduced freshwater usage, with most environmental and diversity objectives described as on track. The board upheld its 40% payout framework, declaring $0.2 billion in dividends, albeit at a lower per-share level than previous periods. Management characterised 2025 as a pivotal year focused on reshaping the portfolio, strengthening the balance sheet and laying foundations for long-term value creation through a more concentrated, growth-oriented asset mix.

    From a market perspective, sentiment is supported by positive technical momentum and the strategic implications of the Teck transaction. However, the negative earnings profile and relatively modest dividend yield weigh on valuation metrics, tempering the overall outlook despite progress on strategic objectives.

    More about Anglo American

    Anglo American is a diversified global mining company with core operations spanning copper, premium iron ore, manganese and crop nutrients. De Beers remains part of continuing operations under current accounting treatment. The group is actively repositioning toward critical minerals, with its proposed merger with Canada’s Teck intended to create a copper-focused mining leader positioned to benefit from long-term electrification and decarbonisation trends.

  • Aston Martin Lagonda Global Holdings plc to Monetise F1 Naming Rights as 2025 Performance Softens

    Aston Martin Lagonda Global Holdings plc to Monetise F1 Naming Rights as 2025 Performance Softens

    Aston Martin Lagonda (LSE:AML) has reached an agreement in principle to sell the perpetual rights to use the Aston Martin name and chassis designation for the Aston Martin Formula 1 Team to AMR GP Holdings for £50 million. The transaction also covers certain F1-related branding rights.

    Because Executive Chairman Lawrence Stroll is connected to AMR GP, the deal qualifies as a substantial property transaction and related-party arrangement under UK Listing Rules. Shareholder approval is required, although backing is effectively assured, with investors representing 54.27% of the issued share capital already committed to vote in favour.

    Alongside the announcement, the company provided a trading update for 2025. Wholesale volumes totalled 5,448 vehicles, down from 6,030 the previous year, reflecting fewer high-margin special models and the impact of U.S. tariffs. Adjusted EBIT is expected to land slightly below the lower end of analyst forecasts.

    Cost-reduction initiatives have helped lower operating expenses and capital expenditure, while liquidity remained broadly stable at £250 million. Management anticipates that proceeds from the naming-rights sale, combined with a stronger product mix — including around 500 deliveries of the Valhalla — will support a meaningful financial recovery in 2026.

    The company’s independent directors, advised by Goldman Sachs International, have concluded that the terms of the transaction are fair and reasonable for shareholders. Strategically, the move unlocks value from Aston Martin’s Formula 1 association while maintaining its longer-term sponsorship presence, potentially reinforcing the balance sheet as the group continues its transformation programme and expands its model portfolio in a challenging luxury automotive market.

    From an investment standpoint, the outlook remains constrained by elevated leverage and ongoing losses. While short-term technical indicators show signs of recovery, the longer-term trend is still fragile. Valuation metrics are pressured by negative earnings, and macroeconomic headwinds continue to pose risks despite management’s efforts to stabilise operations and reposition the brand.

    More about Aston Martin Lagonda Global Holdings plc

    Aston Martin Lagonda is a British ultra-luxury performance car manufacturer headquartered in Gaydon, England. The company produces high-end sports cars and SUVs — including the Vantage, DB12, Vanquish, DBX and Valhalla — blending advanced engineering with traditional craftsmanship. Its vehicles are sold in more than 50 countries worldwide, with SUV production based in St Athan, Wales.

  • Pulsar Helium Inc. Raises £7.4m to Fast-Track U.S. Development Projects

    Pulsar Helium Inc. Raises £7.4m to Fast-Track U.S. Development Projects

    Pulsar Helium (LSE:PLSR) has secured approximately £7.4 million through an accelerated bookbuild placing in the UK, issuing 9,191,175 new shares at £0.80 per share. The transaction was led by OAK Securities as sole bookrunner and attracted participation from both new institutional and other investors. Admission of the new shares to trading on AIM is anticipated on or around 27 February 2026, subject to approval from the TSX Venture Exchange. Following admission, the company’s total voting share capital is expected to increase to 180,142,697 shares.

    The majority of the net proceeds will be directed toward advancing the Topaz helium project in Minnesota. Planned activities include extended well testing, further reservoir analysis, additional seismic surveys and completion of a pre-feasibility study covering integrated helium and carbon dioxide production. The company also intends to place deposits on long-lead processing equipment to support project timelines.

    A portion of the funds will be allocated to early-stage geophysical and geochemical exploration at the Falcon project in Michigan, alongside general working capital. Management believes the capital injection will accelerate development across its portfolio and reinforce its positioning in the emerging primary helium sector.

    More about Pulsar Helium, Inc.

    Pulsar Helium Inc. is a publicly listed primary helium exploration and development company, quoted on AIM, the TSX Venture Exchange and the OTCQB. Its asset base includes the flagship Topaz project in Minnesota, the Falcon project in Michigan and the Tunu project in Greenland. The company focuses on identifying and developing primary helium resources not associated with hydrocarbons, targeting first-mover opportunities in stable jurisdictions.

    Pulsar’s strategy centres on building an integrated helium production and processing platform across North America and Greenland, positioning the group to benefit from tightening global helium supply and increasing demand from technology, healthcare and industrial markets.